PKALProject Kaleidoscope
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
AAC&U officials said Mack, who had already been engaged with AAC&U's Institute on Integrative Learning and the Departments, is a "perfect successor" to outgoing PKAL executive director Susan Elrod.
Mack said PKAL plays an important role in unraveling not only the issue and underlying causes of the underrepresentation of diverse students, but also in facilitating and amplifying evidence-based practices that have the greatest potential to significantly change the trajectory of the representation of diverse STEM students.
The PKAL report relatescomputer technologies to having a large effect in creating the LOF.
It should be noted that since the PKAL survey was performed, there has been a significant increase in the electronic networking of laboratories, researchers and lab offices--communication between these different locations has been increased both in volume and speed.
2004 Selected to serve as a PKAL Leadership Initiative Institution.
The 2001 PKAL change agent roundtable--How can technology be best used to enhance undergraduate SME & T?
PKAL files include similar reports from many institutions.
Surveys of the more than 200 institutions that have participated in PKAL facilities-planning workshops indicate that the pressure for renovation is widespread and the cost daunting.
For the past 20 years, as director of Project Kaleidoscope (PKAL), Narum has significantly impacted science, technology, engineering and mathematics (STEM) programs, pedagogy, facilities, individuals and institutions.
DX-2930, an investigational fully human monoclonal antibody inhibitor of plasma kallikrein (pKal), is being developed by the company as a subcutaneous injection for prevention of HAE attacks. and enriched by the participation of five consultants known for their expertise in ways to promote undergraduate research: Diane Halpern (Halpern 2009), Chandra Mehrotra (Dunn, Mehrotra and Halonen 2004), Jeanne Narum (Narum 2006), Louis Tassinary (Cacioppo, Tassinary and Berntson 2007), and Carole Wade (Wade and Tavris 2010).
DX-2930 is a novel, fully human monoclonal antibody inhibitor of plasma kallikrein (pKal).